Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. (Q54110608)

18 June 2018

title

Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. (English)

1 reference

18 June 2018

Marie-Christine Boutron-Ruault

Agnès Fournier

1

0 references

4

Marie-Christine Boutron-Ruault

1 reference

PMC publication ID

5924370

Françoise Clavel-Chapelon

18 June 2018

5

Françoise Clavel-Chapelon

1 reference

PMC publication ID

5924370

18 June 2018

Nathalie Chabbert-Buffet

6

Nathalie Chabbert-Buffet

1 reference

18 June 2018

Sylvie Mesrine

2

Sylvie Mesrine

1 reference

18 June 2018

Laure Dossus

3

Laure Dossus

1 reference

18 June 2018

language of work or name

English

0 references

publication date

30 April 2014

1 reference

18 June 2018

Breast Cancer Research and Treatment

published in

1 reference

18 June 2018

volume

145

1 reference

18 June 2018

issue

2

1 reference

18 June 2018

page(s)

535-543

1 reference

18 June 2018

https://scigraph.springernature.com/pub.10.1007/s10549-014-2934-6

exact match

0 references

cites work

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Breast cancer after use of estrogen plus progestin in postmenopausal women

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study .

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

The decrease in breast-cancer incidence in 2003 in the United States

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Breast cancer risk with postmenopausal hormonal treatment

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Breast cancer and hormone-replacement therapy in the Million Women Study

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

To block estrogen's synthesis or action: that is the question

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Postmenopausal estrogen and progestin use in relation to breast cancer risk

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Hormone replacement therapy regimens and breast cancer risk(1).

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

Breast cancer and hormone-replacement therapy: the Million Women Study

13 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-014-2934-6

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5924370

A review of human carcinogens—Part A: pharmaceuticals

2 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-014-2934-6

10.1007/S10549-014-2934-6

21 January 2018

Identifiers

DOI

1 reference

18 June 2018

PMC publication ID

5924370

1 reference

18 June 2018

PubMed publication ID

24781971

1 reference

18 June 2018